Refractive errors are ocular disorders that occur when the optical power of the eye produces an object image that is not focused on the retina. Although easily correctable in developed countries, the global burden of uncorrected refractive errors is enormous, with an estimated 145 million visually impaired and 8 million blind individuals.
Audrey Abella spoke with Dr Inez Wong, senior consultant ophthalmologist and director of paediatric ophthalmology and strabismus service at the Eagle Eye Centre in Singapore, on how GPs can manage refractive errors in the primary care setting.
Nonsteroidal anti-inflammatory drugs (NSAIDs) appear to increase the risk of major bleeding, stroke or systemic embolism, and hospitalization among patients with atrial fibrillation (AF), suggest the results of the RE-LY* trial. Moreover, there is no difference in the safety and efficacy of dabigatran etexilate (DE) 150 and 110 mg twice daily relative to warfarin.
Diabetic patients in a decompensated state and who develop type 2 myocardial infarction (MI) have an increased risk for mortality and major adverse cardiac events (MACE), according to a new study. In addition, these patients are potentially at risk for undiagnosed coronary artery disease.
Although many patients with atopic dermatitis (AD) use antihistamines, no high-level evidence exists to prove that nonsedating antihistamines reduce itch in patients with AD or provide benefit in controlling AD symptoms, except perhaps sleep and AD comorbidities such as allergic rhinitis, according to a study.